Perioperative Intravenous Dexamethasone After Unilateral Elective Hip Arthroscopy .
Perioperative Intravenous Dexamethasone Significantly Reduces Postoperative Opioid Requirement and Nausea After Unilateral Elective Hip Arthroscopy: A Randomized Double-blinded Placebo-controlled Trial.
Am J Sports Med . 2024 Apr;52(5):1165-1172.Fifty patients undergoing unilateral elective hip arthroscopy were randomized to receive either intravenous dexamethasone (n=27) or a placebo (n=23). The primary outcome of interest was postoperative pain. Secondary outcomes included opioid consumption, nausea scores, vomiting events, and adverse events up to 12 weeks postoperatively. Outcomes were assessed at 6 hours postoperatively and on postoperative days 1 and 2. Overall, the results revealed that dexamethasone significantly reduced postoperative opioid consumption by 40% and vomiting events, without significant differences in postoperative pain levels. The study concludes that perioperative dexamethasone may be a valuable addition to multimodal pain regimens after hip arthroscopy.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
